Exicure Inc (FRA:2H0)
€ 1.48 0 (0%) Market Cap: 60.66 Mil Enterprise Value: 66.14 Mil PE Ratio: 0 PB Ratio: 41.48 GF Score: 31/100

Exicure Inc at Chardan Genetic Medicines Conference (Virtual) Transcript

Oct 05, 2021 / 03:00PM GMT
Release Date Price: €159 (+8.72%)
Keay Nakae
Chardan - Analyst

It's my pleasure to introduce our next guest from Exicure, Chief Executive Officer, Dr. David Giljohann. The format for the session is a roughly 25 minute fireside chat. (Conference Instructions). So David, welcome. To start, could you provide a couple minutes of introductory comments about the state of the business for Exicure, summarizing your differentiated approach and what's been achieved in 2021 year to date?

David Giljohann
Exicure, Inc. - CEO

Sure thing. Thanks, happy to be here, and thanks to everybody that's joining and watching along. So again my name is David Giljohann; I'm the CEO of Exicure and on behalf of the entire Exicure team, happy to be here presenting about our technology and our Company.

So Exicure is publicly traded under the ticker symbol XCUR and I think we've had a great year for those that have been following along. And of course, as we're looking towards the future, I think many more things for us to look forward to.

For this year, [Jay], everything at Exicure has been about neuro,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot